The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Secondary Hypertension Caused by Endocrine Disorders Except Primary Aldosteronism and Pheochromocytoma

기타 내분비 질환에 의한 고혈압

  • Kim, Dong-Sun (Division of Endocrinology and Metabolism, Department of Internal Medicine, Hanyang University School of Medicine)
  • 김동선 (한양대학교 의과대학 내분비대사내과학교실)
  • Published : 2012.04.01
⟨ Previous Next ⟩

Abstract

Secondary hypertension can account for 15% of hypertension cases. The causes of secondary hypertension mostly come from renal diseases, such as renal parenchymal or renovascular disease, and endocrine diseases. The importance of diagnosing secondary hypertension lies in the fact that it may convert an incurable disease into a potentially curable disease. Even if the underlying disease may not be curable, being able to offer disease specific treatments may often make blood pressure control much easier. The causes of endocrine hypertension include primary aldosteronism, pheochromocytoma, Cushing's syndrome, acromegaly, hyper- or hypothyroidism, hyperparathyroidism and other mineralocorticoid hypertension (e.g. apparent mineralocorticoid excess syndrome, Liddle's syndrome). Primary aldosteronsim, pheochromocytoma, and Cushing's syndrome are among the common causes of endocrine hypertension. The first step in evaluating a patient with suspected endocrine-related hypertension is to exclude other secondary causes, particularly renal disorders. An accurate diagnosis of endocrine hypertension provides the clinician a unique treatment opportunity. This topic review will summarize rare causes of endocrine hypertension except primary aldosteronism and pheochromocytoma.

Keywords

References

  1. William FY Jr. Endocrine hypertension In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 12th ed. Philadelphia: Elsevier/Saunders, 2011:545-577.
  2. Stewart PM. Mineralocorticoid hypertension. Lancet 1999;353:1341-1347. https://doi.org/10.1016/S0140-6736(98)06102-9
  3. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005;365:2125-2136. https://doi.org/10.1016/S0140-6736(05)66736-0
  4. New MI, Geller DS, Fallo F, Wilson RC. Monogenic low renin hypertension. Trends Endocrinol Metab 2005;16:92-97. https://doi.org/10.1016/j.tem.2005.02.011
  5. Mussig K, Wehrmann M, Horger M, Maser-Gluth C, Häring HU, Overkamp D. Adrenocortical carcinoma producing 11-deoxycorticosterone: a rare cause of mineralocorticoid hypertension. J Endocrinol Invest 2005;28:61-65. https://doi.org/10.1007/BF03345531
  6. Kino T, Vottero A, Charmandari E, Chrousos GP. Familial/ sporadic glucocorticoid resistance syndrome and hypertension. Ann N Y Acad Sci 2002;970:101-111. https://doi.org/10.1111/j.1749-6632.2002.tb04416.x
  7. Stewart PM, Corrie JE, Shackleton CH, Edwards CR. Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 1988;82:340-349. https://doi.org/10.1172/JCI113592
  8. Liddle GW, Bledsoe T, Coppage WS Jr. A familial renal disorder stimulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 1963;76:199-213.
  9. Sacerdote A, Weiss K, Tran T, Rokeya Noor B, McFarlane SI. Hypertension in patients with Cushing's disease: pathophysiology, diagnosis, and management. Curr Hypertens Rep 2005;7:212-218. https://doi.org/10.1007/s11906-005-0013-4
  10. Baid S, Nieman LK. Glucocorticoid excess and hypertension. Curr Hypertens Rep 2004;6:493-499. https://doi.org/10.1007/s11906-004-0046-0
  11. Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep 2003;5:513-520. https://doi.org/10.1007/s11906-003-0060-7
  12. Streeten DH, Anderson GH Jr, Howland T, Chiang R, Smulyan H. Effects of thyroid function on blood pressure: recognition of hypothyroid hypertension. Hypertension 1988;11:78-83. https://doi.org/10.1161/01.HYP.11.1.78
  13. Richards AM, Espiner EA, Nicholls MG, Ikram H, Hamilton EJ, Maslowski AH. Hormone, calcium and blood pressure relationships in primary hyperparathyroidism. J Hypertens 1988;6:747-752. Erratum in: J Hypertens 1988;6:ii. https://doi.org/10.1097/00004872-198809000-00009
  14. Sancho JJ, Rouco J, Riera-Vidal R, Sitges-Serra A. Longterm effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J Surg 1992;16:732-735. https://doi.org/10.1007/BF02067371
  15. Terzolo M, Matrella C, Boccuzzi A, et al. Twenty-four hour profile of blood pressure in patients with acromegaly: correlation with demographic, clinical and hormonal features. J Endocrinol Invest 1999;22:48-54. https://doi.org/10.1007/BF03345478